Oct 29, 2025Catalent launches new corporate brand | Lonza to acquire Redberry SAS

Oct 28, 2025The state of biopharma resilience in 2025 | Hovione doubles US spray drying capacity

Oct 25, 2025Lonza, Thermo Fisher report strong Q3 | Galderma to invest $650M in US manufacturing

Oct 24, 2025Lonza reports strong CDMO performance in Q3 | Sharp invests $100M in US, European sites

Oct 23, 2025Thermo Fisher expects benefit from customers’ US investment | Cambrex invests $120M in US operations

Oct 22, 2025MilliporeSigma positions for ADC growth | ACG invests $200M in its first US empty-capsule facility

Oct 21, 2025Key starting material dependence puts US at risk | Merck breaks ground on $3B Virginia plant

Oct 18, 2025Novo Nordisk’s Indiana plant has history of issues | FDA priority vouchers target US manufacturing

Oct 17, 2025Charles River adjusts to headwinds in CDMO business | AstraZeneca invests $445M in Texas plant

Oct 16, 2025AI-digital twin boosts pharma manufacturing | MilliporeSigma buys chromatography business

Oct 15, 2025Novo Nordisk’s troubled Indiana site | Recipharm’s new parenteral development, sterility labs

Oct 14, 2025VA battles NC for biomanufacturing dollars | Trump’s drug-price deal with AstraZeneca

Oct 11, 2025Cell and gene therapy challenges, opportunities | AstraZeneca’s $4.5B Virginia facility

Oct 10, 2025The top 5 US biomanufacturing hubs | Lonza gets approval for drug product filling line

Oct 9, 2025Supply chain hurdles in CGT manufacturing | Recipharm facility becomes analytical services hub

Oct 8, 2025New standard for cell and gene therapy manufacturing | Lonza expands CGT portfolio

Oct 7, 2025FDA incentivizes US generic drug manufacturing | Eli Lilly to invest $1B in India

Oct 4, 2025Trump’s tariffs a bluff or does he mean business? | Thermo Fisher’s $1B fill-finish deal

Oct 3, 2025Trump delays pharma tariffs amid pricing talks | Pfizer gets tariff reprieve, lowers US drug prices

Oct 2, 2025FDA gets industry feedback on onshoring program | Spain’s Rovi acquires BMS facility in Phoenix

Oct 1, 2025Hans Scientific invests $2B as Trump’s pharma tariff looms | Avid’s new CEO says CDMO poised for growth

Sep 30, 2025Ohio’s $30M biomanufacturing training center | Amgen lays out $650M to grow Puerto Rico site

Sep 27, 2025Trump threatens 100% pharma tariff starts Oct. 1 | NC’s biomanufacturing boom has challenges

Sep 26, 2025Fujifilm opens $3.2B NC biomanufacturing site | Thermo Fisher equips new Korean viral vector facility

Sep 25, 2025Eli Lilly to build $6.5B API site in Texas | Celltrion acquires Eli Lilly’s NJ biologics plant

Latest Edition